{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-005258","form_type":"8-K","ticker":null,"cik":"0001839133","company_name":"IR-Med, Inc.","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.476997+00:00","generated_at":"2026-05-16T04:32:33.904120+00:00","sec_items":["1.01","3.02","5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"IR-Med raises $43,619 from director-led private placement; CEO Ran Ziskind resigns","bullets":["Gross proceeds of $43,619 from sale of 14,070,644 shares at $0.0031 and warrants for 7,035,322 shares at $0.03.","Directors Oded Bashan, Yaniv Cohen, Yechiel Even, Ron Mayron, and Aharon Klein participated in the offering.","CEO Ran Ziskind resigned effective February 3, 2026, citing disagreements on strategic direction and management.","Warrants have a 5-year term and are immediately exercisable at $0.03 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-005258","json":"https://secwatch.observer/filing/0001493152-26-005258.json","markdown":"https://secwatch.observer/filing/0001493152-26-005258.md","text":"https://secwatch.observer/filing/0001493152-26-005258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839133/000149315226005258/0001493152-26-005258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839133/000149315226005258/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:32:33.904120+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f6192778665476801602d9d1b3f1283982c75718","claim":"IR-Med, Inc. entered into Securities Purchase Agreement with certain investors valued at aggregate gross proceeds of $43,619 (effective 2026-02-04).","evidence_excerpt":"On February 4, 2026, IR-Med, Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (each an “Investor” and, collectively, the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement offering (the “Offering”), an aggregate of 14,070,644 shares of the Company’s common stock, par value $0.001 per share, (the “Common Stock”), at a per share price of $0.0031 and a warrant to purchase up to an additional 7,035,322 shares of Common Stock (the “Warrants”) at a per share exercise price of $0.03 (the “Exercise Price”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839133/000149315226005258/0001493152-26-005258-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors"},{"label":"Value","value":"aggregate gross proceeds of $43,619"},{"label":"Effective","value":"2026-02-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}